EXTRAMURALLY FUNDED AWARDS OVER $100K



In the spotlight

NCI

• Mark Day, Ph.D. R21 ($257K) for “Delineation of tumor, stromal and immune transcriptomes at the infiltrating interface of muscle invasive bladder cancer.” (CB)

• Corey Speers, M.D., Ph.D. R21 ($257K) for “Elucidating the role of androgen receptor (AR) in mediating radioresistance in AR-positive breast cancer .” (TACR)

• Weiping Zou, M.D., Ph.D. R01 ($2M) for “CTL-killing capacity and cancer stiffness in cancer immunity and therapy .” (CHI)

NIH

• Maria Castro, Ph.D. R01 ($338K) from The National Institute of Neurological Disorders and Stroke for “Uncover the role of H3.3-G343R mutation in shaping the DNA damage response, anti-tumor immunity and mechanisms of resistance in glioma.” (CHI)

External Awards

• Erin Cobain, M.D. $405K from the American Cancer Society for “Tumor/normal genomic profiling to identify and characterize pathogenic germline variants in metastatic cancer.” (TACR)

• Arul Chinnaiyan, M.D., Ph.D. and Abhijit Parolia $225K from the Prostate Cancer Foundation for “Delineating class-specific pathobiology and therapeutic vulnerabilities of FOXA1-altered prostate cancers.” (CG)

• Joerg Lahann, Ph.D. $193K from Gradalis, Inc. for “Using a 3D Engineered Scaffold for Large-Scale Vigil® Autologous Tumor Cell Vaccine Production.” (CB)

• Moshe Talpaz, M.D. $320K from Bristol-Myers Squibb Company for “Exploring new mechanisms of Fedratinib activity in Myelofibrosis.” (CHI)

• Sriram Venneti, M.D., Ph.D. $144K from the Chad Tough Foundation for “Therapeutic targeting of the PBAF chromatin remodeling complex in diffuse intrinsic pontine gliomas.” (CG) 

Internal Awards